How can you infuse your company main functions – from R&D to commercial activities – with digital innovation? Explore what digital maturity means for biopharma and what new doors omnichannel, customer experiences, digital medicine etc can open on the path to becoming a “digital first” pharma company.

In this session, moderated by John Kutz, EVERSANA MANAGEMENT CONSULTING, you will hear from key executives on the following topics:

- Generative AI in Pharma [Talk] - Abid Rahman, EVERSANA 

Opportunities for pharma with generative AI: Accelerating content and personalizing interactions “Pharmatizing” generative AI – Balancing innovation and risk Bringing generative AI to life in pharma with use cases

- AI Enhanced Care Pathways [Talk] - Pierantonio Russo, EVERSANA 

Opportunities for artificial intelligence (AI) and machine learning (ML) to transform the care journey Finding patients and accelerating time to diagnosis using AI/ML Measuring and optimizing clinical outcomes and medical costs with AI/ML Surfacing barriers to adherence and targeting with interventions using AI/ML

- Precision Engagement [Talk] - James May, Healthware Engage 

How 4IR (4th Industrial Revolution) is impacting the patient journey The funnel of engagement – from passive to active to interactive From KPIs to CXIs (Customer Experience Indicators) 

- Leveraging digital medicine and telehealth for pharma [Talk] - Alberta Spreafico, Healthware Group 

Digital medicines: opportunities, around and beyond the pill, for pharma GTM Strategies for pharma to effectively launch and scale digital medicines Driving adoption and impact in an evolving ecosystem

- How Can Pharma Get a Digital Advantage? [Panel Discussion] 

This discussion will focus on how pharma companies are laying a foundation for long term differentiation and advantage by digitally enabling key areas like R&D, Medical Affairs, Marketing, Field, and Patient Support as well as deploying new digital treatments.

Key objectives for the panel: Explore the myriad of ways pharma companies are putting digital technologies and AI to work and creating competitive advantages. Specifically, we will explore: 

• Accelerating clinical trials and real-world evidence gathering through remote monitoring, engaging patient support tools and AI-enabled coaching 
• Building meaningful relationships with patients and doctors through early screening, virtual care and patient support services that engage patients earlier in their journey and stay with them longer 
• Treating conditions through effective, proven and readily accessible digital health platforms in areas like chronic pain, mental health and weight loss 

Moderator: John Kutz, EVERSANA MANAGEMENT CONSULTING 

• Mariangela Amoroso, Sanofi 
• Ozgun Demir, Genentech 
• Steven Januar Kusmanto, Menarini 
• Gazal Vakili, Sumitomo Pharma